Fintech PR
A Groundbreaking Initiative in Israel’s Banking System – A Bank and a Fintech Company Join Forces: Leumi and Tarya Fintech Sign Strategic Partnership Agreement to Jointly Develop an Innovative Core System for Leumi’s Mortgage Operations
Leumi (TASE: LUMI) and Tarya Fintech have joined forces in a strategic initiative to develop and adapt Leumi’s (core) mortgage system, as part of the Bank’s modernization project. The synergy between Tarya Fintech’s innovative technology and unique DNA and Leumi’s technological leadership, experience and knowledge will lead to the creation of an innovative, agile and customizable digital mortgage platform. The system will be developed with a holistic view of customers’ needs and financial decisions at various stages of their lives.
Although mortgage credit is one of the major areas of activity in the banking system (more than 30% of banks’ credit portfolio is comprised of mortgages), the process of taking out a mortgage loan is often highly cumbersome. The new system will alter the way mortgages are obtained, giving customers a state-of-the-art, user friendly and transparent experience across the entire process, at the time and place of the customer’s choosing. The system will offer unique capabilities, new to the world of banking, with the aim of cutting red tape, shortening underwriting processes and simplifying the various approvals required – in order to offer customers a concise, speedy response, tailored to their needs.
The system, which is currently under development, will be available for use by Leumi and Tarya Israel in Israel; Tarya Fintech will be able to use the system to serve its customers worldwide.
Leumi, one of Israel’s leading banks, is considered a pioneering innovator in the field of banking: as early as 2016, it became the first bank in the country to use cloud technology; in 2017, it established PEPPER, Israel’s first digital bank; and recently, it launched a fully-digital mortgage loan, which also enables customers to obtain mortgage consulting services over Zoom. Jointly developing the system with Tarya will allow the Bank to make a groundbreaking leap in the field of mortgages.
Tarya was established in 2014 and has become Israel’s largest P2P lending company. Tarya leads the market through its digital system for alternative investments, most of which are backed by real estate collateral; among other things, the company has extended mortgages totaling approx. NIS 1 billion to the general public. Since its inception, over NIS 4.5 billion has been processed through Tarya’s platform. The company’s outstanding loans portfolio, backed by the company’s real estate collateral, totals over NIS 2 billion.
Founded by Eyal Elhayany, Varda Lusthaus and Assaf Shlush, Tarya has gained traction with a series of unique technological developments. Among other things, the company has developed a smart algorithm that generates a virtual credit rating that is able to predict the borrower’s repayment capacity.
In December 2020, it was reported that Tarya Israel is expected to go public, by way of a merger into public company skeleton Luzon Real Estate, controlled by businessman Amos Luzon.
Hanan Friedman, President & CEO of Leumi: “Leumi leverages its technological-digital strategy – which has proven itself over the past year – through collaborations with fintech companies. This is key to tomorrow’s banking, that is all the more relevant given the imminent entry of the open banking reform, which we regard as an opportunity. Leumi intends to be a leader in collaborations and the first choice of fintech companies, in order to bring innovative service value to customers of all banks. The collaboration with Tarya will further strengthen our business focus on mortgages and allow us to take another leap forward in the rapid launch of disruptive products”.
Jaime Schcolnik, Head of Leumi’s Technologies Division: “Leumi is in the process of technological innovation, which includes building a technological architecture that enables a leap into the future. In this framework, we leverage technological collaborations with fintech, enabling them to connect to the Bank’s systems, as part of the open banking reform. The unique collaboration with Tarya will lead to the development of a modern mortgage platform that will provide a swift, varied response to customers’ needs”.
Tarya Israel CEO, Shahaf Erlich: “I welcome the important deal with Bank Leumi, which is reflective of the new world of banking. Together with Leumi, Tarya will develop a cutting edge technology to improve customer experience and revolutionize the mortgage market”.
Assaf Shlush, Founder and CEO of Tarya Fintech: “We are proud to lead the first-of-its-kind joint initiative between a fintech and a leading bank. For the first time in Israel, a fintech with a proven financial technology platform and extensive international experience joins forces with an Israeli bank which is at the forefront of substantial modernization, as a true fintech partner, to jointly develop a core system. We thank Leumi – which champions an innovative approach to digital banking – for choosing Tarya Fintech to lead the development of the core mortgage system. We believe that this joint initiative is the first step in a strategic cooperation aimed at leveraging strengths, boosting joint growth and creating significant added value for customers in Israel“.
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
“The Hainan FTP and Me”: Looking at Hainan’s Transformations
-
Latest News5 days ago
Millions of people unite around doing good on the 18th International Good Deeds Day held yesterday worldwide
-
Latest News4 days ago
Banxso Acquires Australian ASIC License, Enhancing Its Global Trading Operations
-
Latest News5 days ago
135th Canton Fair Launches a Showcase of Innovative Products of New Collection to Lead Global Market Trends
-
Latest News3 days ago
BMO Announces Election of Board of Directors
-
Latest News5 days ago
BII and FMO back BECIS with joint US$50 million financing facility supporting commercial and industrial renewables sector in South-East Asia
-
Latest News5 days ago
Silent Eight secures AIA as its latest client
-
Latest News5 days ago
JLL Asia Pacific Awarded Frost & Sullivan’s 2023 APAC Company of the Year Award for Delivering a Broad Product Portfolio That Meets Industry Demands and Customer Expectations